Ginkgo Bioworks (DNA) Reports In-Line Q1 EPS, misses on revenue

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $37.94 million versus the consensus estimate of $46.37 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• HSBC Raises S&P500 Target to 8,100
• After an 18% summer selloff in chip stocks, Citi asks what comes next